Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 6/20 | 0.70 |
| ▸ | SLC6A3 | Q01959 | 6/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.56 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | THPO | P40225 | 1/20 | 0.56 |
| ▸ | MTOR | P42345 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11068578 | 0.89 | SLC6A4 (0.85) | SLC6A4SLC6A3ALDH1A1MEN1NPC1 | |
| Hydrochloric Acid SCHEMBL10638536 | 0.88 | SLC6A4 (0.74) | SLC6A4SLC6A3ALDH1A1MEN1LMNA | |
| SCHEMBL7721328 | 0.83 | SLC6A4 (1.00) | SLC6A4SLC6A3SLC6A2 | |
| Hydrochloric Acid SCHEMBL11077830 | 0.82 | SLC6A4 (0.98) | SLC6A4SLC6A3ALDH1A1MEN1LMNA | |
| SCHEMBL10638396 | 0.82 | SLC6A4 (0.88) | SLC6A4SLC6A3SIGMAR1 | |
| Hydrochloric Acid SCHEMBL10635558 | 0.81 | SLC6A4 (0.86) | SLC6A4SLC6A3LMNASIGMAR1 | |
| SCHEMBL10552245 | 0.81 | SLC6A4 (0.78) | SLC6A4SLC6A3ALDH1A1MEN1NPC1 | |
| SCHEMBL10550540 | 0.81 | SLC6A4 (0.78) | SLC6A4SLC6A3ALDH1A1MEN1NPC1 | |
| SCHEMBL11828414 | 0.79 | TSHR (0.64) | ALDH1A1POLBMEN1TSHRKMT2A | |
| SCHEMBL11833152 | 0.79 | TSHR (0.64) | SLC6A4ALDH1A1POLBMEN1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| CN-101330905-A | Freeze-drying process and products obtained thereby | SCIDOSE LLC (US) | 2008-12-24 | — | — | CN | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| EP-0194336-A2 | Oral mobenzoxamine preparation | Taiyo Pharmaceutical Industry Co., Ltd. (JP) | 1986-09-17 | — | — | EP | claimed |
| US-4608366-A | CLATHRATES; ANTISPASMODIC AGENTS, ANTIEMETICS | TAIYO PHARMACEUTICAL INDUSTRY CO., LTD. (JP) | 1986-08-26 | — | — | US | claimed |
| JP-62148423-A | — | — | None | — | — | JP | disclosed |
| JP-61207380-A | — | — | None | — | — | JP | disclosed |
| US-20220047505-A1 | Controlled Absorption Water-Soluble Pharmaceutically Active Organic Compound Formulation for Once-Daily Administration | STI PHARMA, LLC (US) | 2022-02-17 | — | — | US | disclosed |
| US-11191719-B2 | Controlled absorption water-soluble pharmaceutically active organic compound formulation for once-daily administration | STI PHARMA, LLC (US) | 2021-12-07 | — | — | US | disclosed |
| US-10463611-B2 | Controlled absorption water-soluble pharmaceutically active organic compound formulation for once-daily administration | STI PHARMA, LLC (US) | 2019-11-05 | — | — | US | disclosed |
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | disclosed |
| EP-0194336-A2 | Oral mobenzoxamine preparation | Taiyo Pharmaceutical Industry Co., Ltd. (JP) | 1986-09-17 | — | — | EP | disclosed |
| EP-0194336-A2 | Oral mobenzoxamine preparation | Taiyo Pharmaceutical Industry Co., Ltd. (JP) | 1986-09-17 | — | — | EP | disclosed |
| JP-S61207380-A | ORAL PREPARATION OF MOBENZOXAMINE | TAIYO YAKUHIN KOGYO KK | 1986-09-13 | — | — | JP | disclosed |
| US-4608366-A | CLATHRATES; ANTISPASMODIC AGENTS, ANTIEMETICS | TAIYO PHARMACEUTICAL INDUSTRY CO., LTD. (JP) | 1986-08-26 | — | — | US | disclosed |
| US-4608366-A | CLATHRATES; ANTISPASMODIC AGENTS, ANTIEMETICS | TAIYO PHARMACEUTICAL INDUSTRY CO., LTD. (JP) | 1986-08-26 | — | — | US | disclosed |
| US-4608366-A | CLATHRATES; ANTISPASMODIC AGENTS, ANTIEMETICS | TAIYO PHARMACEUTICAL INDUSTRY CO., LTD. (JP) | 1986-08-26 | — | — | US | disclosed |